Updated Integrated Safety Analysis of Ritlecitinib up to ~5 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials. J of Skin 2025, 9 (6), s669. https://doi.org/10.25251/2vrcdb23.